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ABSTRACT: Objective: To characterize spatiotemporal patterns of  operational indicators for leprosy control 
in the state of  Bahia from 2001 to 2014. Methods: This is a population-based ecological study, with spatial 
distribution and autocorrelation of  operational indicators for leprosy control. Results: From 2001 to 2007, 42.7% 
(n=178) of  the municipalities presented a cure rate lower than 75%, increasing to 61.4% (n =291) from 2009 to 
2014. Between 2001 and 2007, 32.5% (n=54) of  the municipalities reported more than 10% of  the total number 
of  relapses in the state, increasing to 36.9% (n=75) between 2008 and 2014. From 2001 to 2014, 38% (n=159) 
of  the municipalities presented an assessment index of  disability grading at the time of  diagnosis within the 
regular performance parameter. Between 2009 and 2014, the number of  municipalities with a high incidence 
of  grade 2 disability (G2D) at the time of  diagnosis increased, reaching 55.3% (n=230) of  the municipalities. 
Most municipalities in the state of  Bahia showed poor performance in the implementation of  planned actions 
for leprosy control, with little change or relative worsening in the patterns of  operational indicators throughout 
the historical series. Conclusion: The operational context in Bahia indicates significant institutional vulnerability, 
leading to the need for expansion and qualification of  the surveillance and health care network in the different 
regions and conditions analyzed in the public health system (Sistema Único de Saúde – SUS).
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INTRODUCTION 
Leprosy is a chronic condition with high potential to cause physical disabilities due to 
neural damage, in addition to esthetic damage and stigma. It is a persistent public health 
problem in Brazil, presenting a heterogeneous and focal distribution in areas with different 
levels of  endemicity1-3.
Leprosy affects mainly people in situations of  significant vulnerability. Its neglected 
disease nature gives leprosy relative priority in the implementation of  political agendas to 
tackle the condition in terms of  health surveillance, control, care, and education4-6. Its con-
trol involves the development of  intersectoral actions to fight poverty and social inequali-
ties so as to reduce its incidence7,8, in addition to structuring an integral and effective care 
network for people affected9. 
In Brazil, individuals, families, and communities affected or at risk of  acquiring leprosy 
should find its main locus of  care in primary health care (PHC)4,9. Since PHC is closer to 
people’s everyday lives, including their family dynamics and household and social contact 
networks, it has a greater potential to identify and meet health needs, integrating the devel-
opment of  surveillance actions to interrupt transmission in the territories9.
Due to its slow development and prolonged treatment, leprosy requires follow-up 
to promote adherence to the treatment prescribed, prevent and monitor adverse 
events and leprosy reactions, encourage self-care, prevent and rehabilitate physical 
disabilities, intensify the active search for new cases, and implement the surveillance 
RESUMO: Objetivo: Caracterizar padrões espaçotemporais de indicadores operacionais de controle da hanseníase 
no estado da Bahia no período de 2001 a 2014. Metodologia: Estudo ecológico, de base populacional, com 
distribuição e autocorrelação espacial de indicadores operacionais da hanseníase. Resultados: No período de 
2001 a 2007, 42,7% (n = 178) dos municípios apresentaram percentual de cura inferior a 75%, ampliando para 
61,4% (n = 291) de 2009 a 2014. De 2001 a 2007, 32,5% (n = 54) dos municípios notificaram mais de 10% do 
total de casos de recidiva do estado, com aumento para 36,9% (n = 75) dessa situação no período de 2008 a 
2014. De 2001 a 2014, em 38% (n = 159) dos municípios, o indicador de avaliação do grau de incapacidade 
física (GIF) no momento do diagnóstico se encontrava conforme o parâmetro regular de desempenho. Já no 
período de 2009 a 2014, houve aumento de municípios com alta ocorrência de GIF2 no momento do diagnóstico, 
atingindo 55,3% (n = 230) dos municípios. A maioria dos municípios do estado da Bahia apresentou desempenho 
insatisfatório na execução das ações de controle previstas para a hanseníase, com pouca mudança ou relativa 
piora nos padrões de indicadores operacionais ao longo da série histórica. Conclusão: O contexto operacional 
do estado da Bahia sinaliza graves dimensões de vulnerabilidade institucional, o que implica necessariamente a 
ampliação e a qualificação da rede de vigilância e atenção à saúde nas diferentes regiões e contextos analisados 
do Sistema Único de Saúde (SUS).
Palavras-chave: Hanseníase. Epidemiologia. Vigilância. Brasil.
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of  new cases and their contacts, among other1,4,10. However, operational difficulties 
need to be overcome to ensure the performance of  these actions in the different real-
ities of  the country11. 
Aiming to analyze and monitor the actions developed to control the disease, the 
Ministry of  Health (MoH) recommends the use of  operational indicators that allow eval-
uating the quality of  the follow-up performed by health services, including the proportion 
of  patients discharged as cured or who discontinued their treatment during the cohort 
years and the proportion of  new cases of  relapse. Relapse can indicate therapeutic fail-
ure, as well as reinfection and difficulty in differentiating leprosy reactions from relapses 
among health professionals4. 
Considering the natural history of  leprosy, assessing the individual’s neural function is 
essential, given the inherent risk of  infection by Mycobacterium leprae. Thus, operationaliz-
ing disability grading becomes strategical3,4. Disability grading can vary between 0, 1, and 
2, with grade 2 disability (G2D) corresponding to more severe cases. The proportion of  
patients who had their disability graded at the time of  diagnosis and the number of  them 
who presented G2D indirectly measure the coverage and quality of  actions for the timely 
detection of  cases and the monitoring of  neural damage4,11. 
In this scenario, the present study aimed to characterize the spatiotemporal patterns of  
operational indicators for leprosy control in the state of  Bahia from 2001 to 2014. It includes 
the 417 municipalities of  Bahia and uses space as a category of  analysis to provide signifi-
cant information for surveillance in the territories12.
METHODS
STUDY DESIGN AND DATA SOURCES
This is a population-based ecological study, with spatiotemporal analysis of  opera-
tional indicators for leprosy control. We used secondary data from the Notifiable Diseases 
Information System (Sistema de Informação de Agravos de Notificação – SINAN) of  the Brazilian 
MoH. The study included new leprosy cases notified from 2001 to 2014, excluding those that 
had “misdiagnosis” as the exit criterion. Georeferencing of  spatial information and analysis 
was based on digital maps of  the municipalities of  Bahia provided by the National Institute 
for Space Research (Instituto Nacional de Pesquisas Espaciais – INPE).
This study was part of  a doctoral dissertation in Public Health presented by Eliana 
Amorim de Souza for the Graduate Program in Public Health at Universidade Federal do 
Ceará (PPGSP-UFC) in 2017. The project was submitted to the Research Ethics Committee 
of  Universidade Federal do Ceará (Certificate of  Presentation for Ethical Consideration – 
Certificado de Apresentação para Apreciação Ética – CAAE: 19258214.2.0000.5054) and approved 
under report number 544,962.
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STUDY SITE
We included all 417 municipalities in the state of  Bahia. With an estimated population 
of  15 million inhabitants for 2015, Bahia is part of  a group of  states with the worst socio-
demographic indicators in the country, particularly regarding the high income concentra-
tion13,14. Administratively, the state is organized in nine health districts15.
STATISTICAL ANALYSIS
We calculated the following operational indicators, according to MoH guidelines4: 
• Cure: proportion of  leprosy cure among the new cases diagnosed in the cohort years; 
• Discontinuation: proportion of  leprosy patients who discontinued their treatment 
among the new cases diagnosed in the cohort years; 
• Relapse: proportion of  relapses among the cases notified during the year; 
• Disability grading: proportion of  new leprosy cases with disability graded at the time 
of  diagnosis; 
• G2D at diagnosis: proportion of  leprosy cases with G2D at the time of  diagnosis 
among the new cases detected and evaluated in the year under analysis4.
We calculated the indicators for the proportion of  cure and treatment discontinuation 
by considering the cohort from 2003 to 2014, as recommended by the MoH4. The remain-
ing indicators were calculated from 2001 to 2014. Disability grading followed the guidelines 
established by the MoH, as well as parameters used to assess each indicator4. For cases of  
relapse, however, the parameters set for territorial analysis were: absence of  cases of  relapse, 
<5%, 5 to 10%, and >10%. We emphasize that, due to operational issues, we did not ana-
lyze the relapse research form, as recommended by the MoH. The variable under analysis 
corresponds to the field ‘case type’ in the form for notification of  leprosy cases and includes 
all those registered as relapse.
Data were combined into municipality centroids to distribute the indicators spatially. 
We established the following intervals: 2001–2007, 2008–2014, and total period. The inter-
vals specified for the indicators calculated in the cohort were: 2003–2008, 2009–2014, and 
total period. We chose these intervals because we did not identify relevant changes in 
smaller ones, resulting in analyses with greater consistency. We calculated the indicators 
by using the total number of  cases for each period. The databases were consolidated in the 
TabWin® software, version 4.2, of  the Technology Department of  the public health sys-
tem (Departamento de Informática do Sistema Único de Saúde – DATASUS-MS – http://data-
sus.saude.gov.br/apresentacao).
We adopted the local Moran method (local index of  spatial association – LISA), which 
compares the indicators for each municipality with those of  its neighbors, to identify possi-
ble areas and patterns of  spatial autocorrelation. For the analysis of  the proportion of  cure 
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among new cases and disability graded at diagnosis, we calculated the proportion of  new 
“non-cured” leprosy cases and new cases with “disability not graded at diagnosis.” The anal-
ysis of  these indicators was inverted to facilitate spatial visualization and interpretation of  
the patterns identified.
We employed the approach used by Moran Maps to construct the maps, considering 
municipalities with a statistically significant difference. General statistical analyses were 
conducted in the Stata software, version 11.2 (StataCorp LP, College Station, TX, USA). 
The software ArcGIS, version 9.3 (Environmental Systems Research Institute – ESRI, 
Redlands, CA, USA), and TerraView, version 4.1 (INPE, São José dos Campos, SP, Brazil), 
were used to process, analyze, and present cartographic data, as well as calculate indicators 
for spatial autocorrelation. 
RESULTS
Out of  a total of  31,688 new leprosy cases that comprised the cohort from 2003 to 2014, 
85.2% were discharged as cured. From 2001 to 2007, 42.7% (n=178) of  municipalities pre-
sented a cure rate lower than 75%. Between 2009 and 2014, this number increased, reach-
ing 61.4% (n=291). All nine health districts in the state had municipalities with this opera-
tional pattern (Figure 1A)
Out of  all cohort cases, 4,689 were not cured. While comparing the proportion of  non-
cured cases in each municipality with its neighbors, we found a spatial autocorrelation. 
From 2003–2008, the southwest district showed an important cluster that disappeared from 
2009–2014. On the other hand, new clusters emerged in the east-central and south districts 
during this period. Between 2003 and 2014, the clusters in the southwest and east-central 
districts remained (Figure 1B).
In the cohort analyzed, 2,730 people had discontinued their treatment, with an annual 
average of  5.5%. A high percentage of  municipalities did not register cases of  treatment 
discontinuation (n= 278; 66.7%). Among those that did (n=139; 33.3%), most of  them had 
less than 10 cases (n=79; 56.8%) reported. From 2009–2014, the number of  municipalities 
in this scenario increased (n=154; 77.9%). The west, east-central, and southwest districts 
showed the highest number of  municipalities with treatment discontinuation (Figure 2A). 
The spatial autocorrelation indicated the clustering of  municipalities from 2003 to 2008, 
with high discontinuation rates in the southwest and east-central districts. Between 2009 
and 2014, the concentration was more expressive in the southwest, south, and northeast 
districts of  the state (Figure 2B).
Bahia presented a significant number of  notifications of  relapse, with an annual mean rate 
of  3.6% of  cases in the period. From 2001–2007, a high number of  municipalities reported 
cases of  relapse (n=166; 40.0%). Among them, 32.5% (n=54) notified more than 10% of  
the total number of  cases, located mainly in the north, west, and far-south districts. From 
2008 to 2014, the number of  municipalities with notification of  relapse increased; 36.9% 
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of  them (n=75) reported more than 10% of  cases, particularly in the north-central district 
(Figure 3A). Between 2001 and 2007, few municipalities showed a spatial association for 
relapse in the south district of  the state. In the following period, new clusters emerged in 
the southwest and east-central districts. The map for the entire period indicates the presence 
of  small clusters in the south, southwest, and east-central districts (Figure 3B).
The mean percentage of  new cases with disability graded at diagnosis was 86.2%. 
Throughout the period, 9.9% (n=3,967) of  patients did not have their disability graded, 
and in 3.6% (n=1,427) of  cases, this information was ignored, as the specific field in the 
SINAN notification form was not filled. From 2001–2007, 41% (n=171) of  municipalities 
had 90% or more new cases with disability graded at the time of  diagnosis. This percent-
age increased to 48% from 2008 to 2014. However, between 2001 and 2014, 38% (n=159) 
of  municipalities had this indicator within the regular performance parameter (≥75 to 
Figure 1. Spatial distribution of the proportion of leprosy cure among new cases diagnosed 
in the cohort years according to (A) municipality and spatial autocorrelation and (B) local 
Moran for the proportion of non-cured cases in the cohort. Bahia, 2003–2008, 2009–2014, 
and 2003–2014.
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89.9%), and 15% (n=65), within the poor performance parameter (<75%). We found a 
greater concentration of  these municipalities in the west, far-south, and east-central dis-
tricts (Figure 4A).
The maps relating to the local Moran (Figure 4B) showed clusters of  cases without dis-
ability graded at diagnosis, especially in the north and south districts of  the state, all involv-
ing a small number of  municipalities (2001–2007). The map for the entire period (2001–2014) 
confirmed the presence of  clusters with poor performance in these same regions.
Among the cases that had their disability graded at the time of  diagnosis, 64.4% (n=25,797) 
were classified as G0D, 17.3% (n=6,942) as G1D, and 4.8% (n=1,921) as G2D. The mean 
proportion of  cases categorized as G2D at the time of  diagnosis in the historical series was 
5.7%. The low proportion of  disability graded at the time of  discharge from the multidrug 
therapy (MDT) prevented the construction of  this indicator following the MoH guidelines4.
Figure 2. Spatial distribution of the proportion of treatment discontinuation among new leprosy 
cases diagnosed in the cohort years according to (A) municipality and spatial autocorrelation and 
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From 2001 to 2008, 45.5% (n=190) of  municipalities reported cases with G2D at the 
time of  diagnosis. Out of  them, 88 (46.3%) notified 10% or more of  the new cases evalu-
ated. These municipalities are located in all health districts of  the state, particularly in the 
southwest and south districts. Between 2009 and 2014, the number of  municipalities with 
a high incidence of  G2D at diagnosis increased, reaching 55.3% (n=230) of  the total, con-
centrated mainly in the west, north, and far-south districts (Figure 5A).
The local Moran analysis revealed areas of  spatial correlation in the southwest, north, 
and northeast districts, indicating municipalities with high detection rates of  cases with G2D 
surrounded by municipalities in the same situation. We identified a reduction in these areas 
of  autocorrelation in the following period and the emergence of  new clusters in municipal-
ities of  the east-central district, with persistence in the southwest of  the state throughout 
the period (Figure 5B). 
Figure 3. Spatial distribution of the proportion of leprosy relapse among the cases notified in 
the year according to (A) municipality and spatial autocorrelation and (B) local Moran. Bahia, 
2001–2007, 2008–2014 and 2001–2014..
Proportion of relapses 
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DISCUSSION
Most municipalities in the state of  Bahia showed poor performance in leprosy con-
trol indicators, with stability or relative worsening in operational patterns over 14 years. 
We found poor or regular performances regarding the quality of  care and follow-up pro-
vided until the cure, in addition to a growing number of  municipalities with incidence 
of  relapse. The performance of  the disability grading at the time of  diagnosis was reg-
ular, while the evaluation of  the G2D indicator revealed low or average effectiveness of  
timely detection in a significant number of  municipalities. Although not the object of  
this study, the integrated analysis of  operational indicators points to potential endemic 
regions hidden in Bahia.
In addition to the considerable detection rate of  new leprosy cases found in Bahia12,15, the 
fact that most municipalities in this study presented a high percentage of  patients who were 
Figure 4. Spatial distribution of the proportion of new leprosy cases with disability graded at the 
time of diagnosis according to (A) municipality and spatial autocorrelation and (B) local Moran 
for new leprosy cases without disability graded at the time of diagnosis. Bahia, 2001–2007, 
2008–2014 and 2001–2014.
Proportion of 
disability grading at 
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not discharged for cure in the recommended period4 increases the possibility of  sources of  
infection that could be drug resistant1,16,17. This situation indicates significant care and sur-
veillance failures and may contribute to physical impairment and stigma1,15-17. A study con-
ducted in Bahia identified areas with a higher burden of  the disease, particularly in the far-
south, north, and west districts15. Some health districts show lower detection coefficients of  
new cases as well as unsatisfactory performance in the number of  individuals discharged as 
cured, making its control even more complex12.
In Brazil, even after the introduction of  MDT, approximately 20% of  patients were not 
cured in the cohort of  2017. This percentage is similar to that found in the state of  Bahia, 
which holds the third-to-last place regarding performance in the Northeast Region18. São Luís 
do Maranhão faces an even more critical situation, considering that out of  the 183 cases 
monitored, only 67.7% were discharged as cured19. Given the efficacy and effectiveness of  
Figure 5. Spatial distribution of the proportion of new leprosy cases with grade 2 disability 
(G2D) at the time of diagnosis among new cases detected and evaluated according to (A) 
municipality and spatial autocorrelation and (B) local Moran. Bahia, 2001–2007, 2008–2014 
and 2001–2014.
Proportion of G2D 
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MDT, failures related to errors of  classification and prescription, treatment irregularity, and 
MDT discontinuation might be associated with the lack of  cure20. 
Also, the notification of  treatment discontinuation is a reality in more than 30% of  
municipalities in Bahia, and small clusters of  municipalities have emerged in areas with 
lower detection rates of  new cases in the state12,15. Therefore, assessment studies addressing 
determining and conditioning factors to identify possible reasons for patients to discon-
tinue their treatment should be encouraged. The absence of  symptoms in early stages, 
the non-acceptance of  the disease, the belief  in religious cure, and the shame related 
to the monthly visits to health units were identified as causes for treatment discontin-
uation in the Brazilian Northeast20. In highly endemic areas in the state of  Tocantins, 
treatment discontinuation was associated with males, illiterate individuals, those with 
multibacillary disease, who have difficulties in the route from home to the health ser-
vice, with one or two people per household, under other treatments before the MDT, 
and who do not believe in cure21. Counseling at diagnosis can be a strategy to strengthen 
bonds, create spaces for listening, promote health education, and adopt behaviors to 
overcome vulnerability22-24.
The number of  municipalities with incidence of  relapse is high, with growth among 
those that reported more than 10% of  this type of  case. We underline that its incidence is 
distributed in the nine health districts15. Thus, reviewing diagnostic criteria, discussing new 
MDT regimens for cases previously treated, and qualifying the follow-up are necessary4,22. 
Leprosy relapse is a complex subject, and its notification should follow the MoH guide-
lines4. In 2015, Brazil was responsible for 42.8% (n=1,452) of  all cases of  relapse reported 
to the World Health Organization (WHO)25. WHO estimates a risk of  incidence of  1.1% 
after implementation of  MDT for paucibacillary cases and 0.8% for multibacillary ones. In a 
study conducted in the state of  Mato Grosso, 64.7% of  municipalities have notified cases 
of  relapse, corresponding to 6–20% of  all cases. The predictive factors found for relapse 
are related to housing conditions, lifestyle habits, organization of  health services, clinical 
forms, and treatment regimen26. Another study conducted in Bahia revealed an increasing 
trend in relapse among males27. In contrast, multicenter research that investigated drug 
resistance in five Brazilian states showed that this event has low magnitude and is present 
in old cases, with a history of  institutionalization and subjected to long-term monotherapy 
regimens with irregular use28.
In addition to qualifying health care, prioritizing the epidemiological investigation of  
cases of  relapse following the criteria recommended by the MoH4 is crucial. This is a key 
measure, considering the importance of  differentiating therapy deficiency, therapeutic fail-
ure, and leprosy reactions, commonly mistaken in health services4,28,29. The diagnosis of  
relapse should be confirmed in reference centers for leprosy4, but most municipalities in 
Bahia do not have proper access to specialized teams in their health districts.
We emphasize the importance of  discussing issues related to professional health train-
ing, with the development of  permanent education procedures and effective policies in 
health education for neglected events. These actions can positively affect the construction 
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of  effective care networks, enabling integrated care, improving cure rates, and reducing 
treatment discontinuation and relapses1,4,28.
The number of  municipalities with regular or poor performance in the disability grad-
ing indicator was high. Similarly, most municipalities notified cases with G2D at the time of  
diagnosis, which increased over time, even in highly endemic areas, such as the west, north, 
and far-south districts of  the state4,12,15. This scenario indicates late diagnosis and weaknesses 
in the development of  actions to promote self-care and physical rehabilitation4.
National data show that Bahia has the fifth worse performance in disability grading in 
the country18, contrary to results of  a study carried out in Londrina, Foz do Iguaçu, and 
Curitiba, whose percentages of  disability grading at diagnosis were above 90%30. In addition 
to expanding the access to disability grading in the municipalities of  Bahia, the quality of  
the examination and its proper notification to SINAN should be improved, since the pro-
portion of  individuals with disability graded and reported at the time of  discharge is mini-
mal. This finding also leads to the need for new studies, particularly operational ones, for a 
better understanding of  the care process established, even in case of  association of  leprosy 
with other debilitating diseases and those of  chronic evolution1,11,31.
This study has potential limitations for being strictly based on secondary data. For instance, 
the low completeness of  SINAN records regarding disability grading at the time of  discharge 
prevented us from analyzing these data. We acknowledge the possibility of  errors concern-
ing the diagnosis of  relapse by health services and the need for further research. This study 
did not find investigations on relapse in the state. However, both as to relapse and other 
indicators, the use of  an extensive state historical series minimizes the effects related to 
non-completeness and inconsistency.
CONCLUSION
Bahia has a significant number of  municipalities with poor or regular patterns of  indi-
cators for cure, relapse, GIF evaluation at diagnosis, and cases with GIF at the time of  
leprosy diagnosis. We underline the need to expand and qualify the surveillance and care 
provided by health services, taking into account the endemic maintenance in the state as 
to parameters of  high endemicity. This scenario indicates the persistence of  leprosy as 
a significant public health issue in Bahia in the coming years if  the current operational 
control does not change.
This study revealed the existence of  municipalities with poor patterns of  operational 
indicators in all nine health districts, confirming the magnitude of  the challenge for one 
of  the largest Brazilian states. Thus, regional and/or municipal research can contribute to 
identifying weaknesses, especially with respect to primary health care, the implementation 
of  leprosy control actions, and integrated care to individuals, families, and communities. 
In addition, we highlight the importance of  strengthening SUS and tackling vulnerabilities 
with intersectoral actions to control leprosy.
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